News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 3047
- Sources here
- 23
- Companies here
- 29
Search results
Stored financial headlines
Active search
3047 matching headlines
Ticker or company: DICMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates
Journey Medical (FBIO) reported a 23% year-over-year revenue increase to $18.5 million in Q2 2026, primarily driven by strong performance from its rosacea product, Emrosi, which generated $8.1 million in net revenue and saw a 20% sequential rise in prescriptions. The company achieved positive …
DERM
main company
Sharemaestro market context
Price above Trend Line
52 weeks -10.0%
Utah Medical Products (NASDAQ:UTMD) Shares Pass Above 200 Day Moving Average - Time to Sell?
Utah Medical Products (NASDAQ:UTMD) shares have risen above their 200-day moving average, reaching $72.37 against an average of $66.51. The company reported quarterly earnings of $0.84 per share on $8.53 million in revenue and declared a $0.31 quarterly dividend, equivalent to a 1.7% annual …
UTMD
main company
Sharemaestro market context
Trend signal active
52 weeks +18.8%
Asset Management One Co. Ltd. Purchases New Position in Medical Properties Trust, Inc. $MPT
Asset Management One Co. Ltd. has acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPT), purchasing 699,754 shares valued at approximately $3.23 million. This new position represents a 0.12% ownership in the company. Medical Properties Trust recently reported quarterly EPS of $0.15 and …
MPT
main company
Sharemaestro market context
Price below Trend Line
52 weeks +4.2%
Why Is Becton Dickinson (BDX) Getting Fresh Attention Today?
Becton Dickinson (BDX) is gaining attention after completing enrollment in its PREVENT clinical trial for Phasix Mesh, a significant step towards future U.S. regulatory submission. The stock has seen strong short-term gains, up over 20% in the last 30 days, raising questions about whether …
BDX
main company
Sharemaestro market context
Price above Trend Line
52 weeks +19.7% · Next-week setup negative 33.9%
Strata critical medical director Reginald Love disposes of $29,273 in stock
Reginald Love, a director at Strata Critical Medical (NASDAQ:SRTA), sold 5,091 shares of the company's Class A common stock for a total of $29,273 on August 10, 2026. Following this transaction, Love still directly holds 146,481 shares. The company's stock has seen significant gains …
SRTA
main company
Sharemaestro market context
Trend signal active
51 weeks +35.0%
Rockwell Medical Releases Q2 2026 Financial Results
Rockwell Medical, Inc. announced strong Q2 2026 financial results, significantly beating Wall Street expectations with an adjusted loss per share of $0.04 against an estimated $0.24 loss. The company reported revenue of $17.8 million, an 11% increase year-over-year, driven by expanding demand for its …
RMTI
main company
Sharemaestro market context
Price below Trend Line
52 weeks -35.0% · Next-week setup negative 41.3%
Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal
Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
SBC Medical Reports 13 Pct Rise In Q2 Revenue, Net Income Jumps 335 Pct
SBC Medical Group Holdings Inc. reported a 13% year-on-year increase in consolidated revenue to US$49 million for Q2 fiscal 2026, with net income surging by 335% to US$11 million. The company attributes this growth to strengthening underlying fundamentals, including the integration of healthcare and …
SBC
main company
Sharemaestro market context
Price above Trend Line
52 weeks -14.7% · Next-week setup negative 38.5%
Retail giant debuts its first immersive sports store in Colorado
Dick's Sporting Goods has launched its first "House of Sport" location in Colorado, situated in Thornton. The grand opening will feature a three-day celebration with appearances by former and current Denver Broncos and Colorado Avalanche stars. This immersive sports store aims to offer a …
DKS
main company
Sharemaestro market context
Price below Trend Line
52 weeks -9.2%
MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates
MediciNova (MNOV) reported a Q2 loss of $0.05 per share, surpassing the Zacks Consensus Estimate of a $0.06 loss and improving from a $0.07 loss a year ago. The company also exceeded revenue estimates, posting $0.46 million against a $0.15 million consensus, though its …
MNOV
main company
Sharemaestro market context
Price below Trend Line
52 weeks -0.2% · Next-week setup negative 41.7%
ICU Medical (ICUI) investor to sell 5,417 shares worth $982K on NASDAQ
ICU Medical shareholder Daniel Woolson plans to sell 5,417 shares of common stock, valued at $982,264.61, on NASDAQ by August 13, 2026. This sale follows a previous transaction three months prior where Woolson sold 2,123 shares for $280,684.80. The shares originate from various performance …
ICUI
main company
Sharemaestro market context
Trend signal active
52 weeks +42.8%
Form 8K Parabilis Medicines For: 13 August By Investing.com
The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000
Parabilis Medicines, Inc. (PBLS) reported its Q2 revenue as $148,000. The company, a clinical-stage biopharmaceutical firm, focuses on developing transformative medicines for "undruggable" protein targets using its proprietary Helicon platform. Analysts currently have a "BUY" consensus for PBLS with an average target price of …
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
Tenon outlines sacropelvic launches over next six to nine months following FDA 510(k) clearance
Earnings Call Insights: Tenon Medical (TNON) Q2 2026 MANAGEMENT VIEW * "Second quarter revenue was $1.3 million, an increase of 127% over the second quarter last year, and gross profit was $0.8 million, an increase of 232% over the prior year period." (CEO, President …
TNON
main company
Sharemaestro market context
Price below Trend Line
52 weeks -90.1% · Next-week setup negative 36.5%
MediciNova (NASDAQ:MNOV) Announces Quarterly Earnings Results
MediciNova (NASDAQ:MNOV) exceeded quarterly earnings expectations, reporting a loss of $0.05 per share against an estimated $0.06 loss, and revenues of $0.46 million, significantly above the $0.07 million forecast. Despite the positive earnings surprise, the company experienced a slight dip in share price to …
MNOV
main company
Sharemaestro market context
Price below Trend Line
52 weeks -0.2% · Next-week setup negative 41.7%